Don’t forget you can visit MyAlerts to manage your alerts at any time.
By Max Mitchell | September 25, 2018
The policy implications of whether taking a drug during pregnancy constitutes child abuse are vast and could implicate everything from the definition…
1 minute read
By Christine Sexton | September 24, 2018
State officials said that more than 92,000 health care providers had registered to use an electronic database that tracks patients who are prescribed controlled substances.
1 minute read
By Jenna Greene | September 21, 2018
The fight between Teva and United Healthcare—which turned in large part on a he-said-she-said dispute with a client about authority to sign a settlement agreement—should scare every lawyer.
1 minute read
By Charles Toutant | September 19, 2018
The ruling came in a suit filed on behalf of a putative class made up of labor unions, insurance companies and other indirect purchasers who say they are charged more for Effexor XR due to various anti-competitive tactics by Wyeth, which is a subsidiary of Pfizer, and Teva.
1 minute read
By Max Mitchell | September 19, 2018
U.S. District Judge Mitchell Goldberg of the Eastern District of Pennsylvania ruled Wednesday that a 2015 memorandum of understanding between United HealthCare Services and three drug companies was binding.
1 minute read
By Scott D. Locke | September 19, 2018
The recent decision 'In re Rembrandt Technologies LP Patent Litigation' is a reminder of both the potential consequence of a patent holder's disingenuous assertion of unintentionality and the challenges that defendants face when raising the improper filing of a petition to revive a lapsed patent as a defense.
1 minute read
By Lizzy McLellan | September 17, 2018
Montgomery McCracken's former chairman is among the group launching St. Louis-based Armstrong Teasdale's first East Coast office.
1 minute read
By Amanda Bronstad | September 13, 2018
On Thursday, Merck urged the Supreme Court to clarify its "clear evidence" holding in Wyeth v. Levine and reverse a 2017 decision that reinstated more than 500 cases over its osteoporosis drug Fosamax.
1 minute read
By Scott Graham | September 13, 2018
Valeant's attempt to disqualify a team of Katten Muchin Rosenman patent litigators led to a showdown Wednesday at the Federal Circuit.
1 minute read
By Scott Graham | September 13, 2018
Valeant's attempt to disqualify a team of Katten Muchin Rosenman patent litigators led to a showdown Wednesday at the Federal Circuit.
1 minute read
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS